Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 7th, 2023%
A developer of treatments for brain disorders and researchers at Stanford University aim to harness ultrasound to deliver drugs in nanoscale particles to precise regions of the brain. . . . → Read More: Biotech, Academic Labs Partner on Ultrasound Brain Therapy
By Alan, on December 1st, 2023%
A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders. . . . → Read More: Partnership to Discover Mental Health Peptides in Milk
By Alan, on November 29th, 2023%
A new challenge competition from XPrize calls for proactive and accessible health care solutions for improving the quality of life among older people worldwide. . . . → Read More: $101M Challenge Seeks Healthy Aging Solutions
By Alan, on November 24th, 2023%
Researchers from university labs in the U.K. are developing models of brain cell interactions using a company’s synthetic human cells derived from stem cells. . . . → Read More: Academic, Industry Labs to Build Brain Cell Models
By Alan, on November 8th, 2023%
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds
By Alan, on October 19th, 2023%
An historically Black medical college and pharmaceutical industry group began a program to increase the numbers of people of African descent in genomic databases. . . . → Read More: Coalition to Boost African Ancestry Genomic Data
By Alan, on October 12th, 2023%
An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up
By Alan, on October 3rd, 2023%
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies
By Alan, on September 28th, 2023%
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks. . . . → Read More: Cardiac Tech Start-Up Partners with Mayo Clinic
By Alan, on September 21st, 2023%
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy. . . . → Read More: Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|